 |
Articles: M&A/Partnerships |
Prior Articles
XenoPort Announces Election of Co-Promotion Option for Solzira
XenoPort, 07/22/09
Major hospital groups pledge $155 billion savings in deal
American Medical News, 07/21/09 Teva Provides Update On Generic Ortho Tri-Cyclen Lo
Teva Pharmaceutical Industries, 07/20/09
Free full text
SW Ontario DI system to reach more hospitals
Canadian Healthcare Technology, 07/20/09
Free full text
MediSolution to integrate Loki's StaffRight
Canadian Healthcare Technology, 07/20/09
Free full text
Morphotek, Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies
Morphotek, 07/17/09
Free full text
Gilead Sciences Announces Agreement With Tibotec Pharmaceuticals to Develop and Commercialize New Fixed-Dose Combination of Truvada and TMC278
Gilead, 07/17/09
Free full text
Morphotek, Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies
Morphotek, 07/17/09
Free full text
Merck and Schering-Plough Resolve Previously Disclosed Investigation Under State Consumer Protection Statutes Related to VYTORIN (ezetimibe/simvastatin) and ZETIA (ezetimibe)
Merck & Co., 07/16/09
Free full text
Covidien Announces License Agreement with Nuvo Research Inc
Covidien, 07/15/09 Covidien Announces License Rights Acquisition Agreement
Covidien, 07/15/09 GE Partners for Imaging Decision Support
HealthDataManagement, 07/15/09 Abbott and GSK to Collaborate on Molecular Diagnostic Test to Select Candidate Patients for Future Cancer Immunotherapy
Abbott, 07/14/09 Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO Patent Litigation
Forest Laboratories, 07/13/09
Free full text
Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal Vet, a New Chemotherapeutic Agent for Dogs
Abbott, 07/13/09 Merck and Co., Inc. and Portola Enter Worldwide License Agreement to Develop and Commercialize Betrixaban, a Novel Investigational Oral Anticoagulant for Cardiovascular Disease
Merck & Co., 07/10/09
Free full text
Bayer CropScience and Monsanto sign cross licensing agreement on herbicide tolerance traits in rapeseed/canola
BayNews International, 07/09/09
Free full text
Amarna Therapeutics B.V. and TNO announce SVac research and development partnership
b3c newswire, 07/09/09 ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
b3c newswire, 07/09/09 euroPLX Introduces Dynamic Partnering Focus Concept, Announces euroPLX 41 Barcelona
b3c newswire, 07/09/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
